Results 151 to 160 of about 122,436 (294)

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen   +3 more
wiley   +1 more source

Reversal of warfarin-coagulopathy: How to improve plasma transfusion practice in a community hospital setting?

open access: diamond, 2019
A Szállaśi   +5 more
openalex   +1 more source

RNA Analysis Uncovers Pathogenic PARN Variant in Dyskeratosis Congenita

open access: yesClinical Genetics, EarlyView.
Using WGS and RNA analysis, we identified a branch point‐disrupting variant in the PARN gene and elucidated its pathogenic molecular mechanism in a child with atypical dyskeratosis congenita presentation. ABSTRACT Dyskeratosis congenita (DC) is a rare genetic disorder caused by impaired telomere maintenance, leading to diverse clinical manifestations ...
Daria Akimova   +3 more
wiley   +1 more source

Digitally Guided Hydraulic Crestal Sinus Floor Elevation Versus Free‐Hand Osteotome Technique: A Single‐Blinded Randomized Controlled Clinical Trial

open access: yesClinical Oral Implants Research, EarlyView.
ABSTRACT Objectives To compare the clinical and radiographic outcomes of crestal sinus floor elevation (SFE) using a digital surgical guide (DSG) and hydraulic sinus lift technique versus the conventional osteotome technique. Methods Patients requiring crestal SFE and single‐implant placement in the posterior maxilla with a minimum of 5 mm of residual ...
Mahsa Enssi   +4 more
wiley   +1 more source

Coagulopathy in a patient with X‐linked hyper‐IgM syndrome who developed Kaposi's sarcoma [PDF]

open access: bronze, 2004
Masayuki Nagasawa   +5 more
openalex   +1 more source

Low Alanine Aminotransferase Blood Activity, a Biomarker of Sarcopenia and Frailty, is Associated With Worse Post‐Total Laryngectomy Clinical Outcomes. A Retrospective Analysis of 427 Patients

open access: yesClinical Otolaryngology, EarlyView.
ABSTRACT Introduction Sarcopenia and frailty status have been shown to be associated with cancer patients' survival. Low alanine aminotransferase (ALT) blood activity was previously shown to be associated with frailty and poor clinical outcomes in cancer patients. This association was not addressed in head and neck cancer patients.
Yarden Tenenbaum Weiss   +8 more
wiley   +1 more source

COVID‐19 and coagulopathy [PDF]

open access: bronze, 2021
Malay Sarkar   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy